LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 16.65
-0.10 (-0.60%)
Jun 12, 2026, 1:59 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 541.99 million as of June 12, 2026. Its market cap has decreased by -6.18% in one year.
Market Cap
541.99M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
16.65
Market Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 541.99M, a decrease of -24.83%. That is a compound annual growth rate of -11.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 541.99M | -28.63% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| U-Neuron Biomedical | 1.00B |
| TCI GENE | 978.96M |
| Lukas Biomedical | 929.61M |
| Taiwan Advance Bio-Pharmaceutical | 913.50M |
| NatureWise Biotech & Medicals | 871.90M |
| MegaPro Biomedical | 805.78M |
| Neith | 791.43M |
| BioLASCO Taiwan | 760.68M |